CTIS/CTR: 1 Year Into its full Application

Presented by

Ruediger Pankow, Parexel International - Scott Feiner, Abbvie

About this talk

The CTR has been into full application since January 2022. In January 2023, all new EU Clinical Trials need to be submitted under the new CTR unto the CTIS. This session consists of an "interim break": where are we? What have been the experiences with the CTIS and CTR after 1 year of its application, from different stakeholders: from sponsors to regulators and national competent authorities?
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (21)
Subscribers (431)
The Drug Information Association (DIA) is a global and neutral association that mobilizes the life science community (regulators, industry, healthcare professionals, patients, payers, and students) to identify and tackle the most complex health challenges. DIA brings all these stakeholders together to find and discuss solutions, build a more robust and innovative healthcare ecosystem and, ultimately, improve patient outcomes worldwide. DIA executes its mission by fostering timely and critical conversations and networking sessions across many platforms, including conferences, workshops, DIA-led research projects, structured training, eLearning courses, digital content platforms, and publications, without corporate funding.